arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Evolent Health, Inc.

EVH
$3.61 ▼ -0.19 (-5.00%) at close
Industrials ·Services-Management Services ·USServices-Management Services
52 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
12
Health
Poor
Bearish
auto_awesome

Analytical Summary

Evolent Health, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $406.3M
Dividend Yield
Revenue Growth 46.9%
Op. Margin -1.5%
ROIC -0.8%
FCF / Share $-0.08
Trailing P/E
Price / Book 1.1x
FCF Yield
Debt / Equity 2.52
info Valuation on last close. End-of-day price, Sep 23, 2026.

52-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$652.52M
↑ +46.9%
Net Income Profit after all expenses
$-28.36M
↓ -42.6%
Operating Margin Operating profit as % of sales
-1.5%
↑ +31.4% 9th
FCF / Share Free cash flow per share
$-0.08
↓ -841.0%
Long-Term Debt Long-term obligations
$966.47M
↓ -0.7%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)
  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
17
Returns
6
Financial Health
11
Cash Quality
19

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 14 years · 52 quarters